Literature DB >> 32248675

Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study

Lowell Ling1, Christina So2, Hoi Ping Shum3, Paul K S Chan4, Christopher K C Lai4, Darshana H Kandamby5, Eunise Ho5, Dominic So5, Wing Wa Yan3, Grace Lui6, Wai Shing Leung7, Man Chun Chan7, Charles D Gomersall8.   

Abstract

Objective: To report the first eight cases of critically ill patients with coronavirus disease 2019 (COVID-19) in Hong Kong, describing the treatments and supportive care they received and their 28-day outcomes. Design: Multicentre retrospective observational cohort study. Setting: Three multidisciplinary intensive care units (ICUs) in Hong Kong. Participants: All adult critically ill patients with confirmed COVID-19 admitted to ICUs in Hong Kong between 22 January and 11 February 2020. Main outcome measure: 28-day mortality.
Results: Eight out of 49 patients with COVID-19 (16%) were admitted to Hong Kong ICUs during the study period. The median age was 64.5 years (range, 42–70) with a median admission Sequential Organ Failure Assessment (SOFA) score of 6 (IQR, 4–7). Six patients (75%) required mechanical ventilation, six patients (75%) required vasopressors and two (25%) required renal replacement therapy. None of the patients required prone ventilation, nitric oxide or extracorporeal membrane oxygenation. The median times to shock reversal and extubation were 9 and 11 days respectively. At 28 days, one patient (12%) had died and the remaining seven (88%) all survived to ICU discharge. Only one of the survivors (14%) still required oxygen at 28 days.
Conclusion: Critically ill patients with COVID-19 often require a moderate duration of mechanical ventilation and vasopressor support. Most of these patients recover and survive to ICU discharge with supportive care using lung protective ventilation strategies, avoiding excess fluids, screening and treating bacterial co-infection, and timely intubation. Lower rather than upper respiratory tract viral burden correlates with clinical severity of illness.

Entities:  

Year:  2020        PMID: 32248675

Source DB:  PubMed          Journal:  Crit Care Resusc        ISSN: 1441-2772            Impact factor:   2.159


  25 in total

1.  Efficacy and safety of hyperbaric oxygen treatment to treat COVID-19 pneumonia: a living systematic review update.

Authors:  Sylvain Boet; Cole Etherington; Nibras Ghanmi; Paul Ioudovski; Andrea C Tricco; Lindsey Sikora; Rita Katznelson
Journal:  Diving Hyperb Med       Date:  2022-06-30       Impact factor: 1.228

2.  Efficacy and safety of hyperbaric oxygen treatment in SARS-COV-2 (COVID-19) pneumonia: a systematic review.

Authors:  Sylvain Boet; Cole Etherington; George Djaiani; Andrea C Tricco; Lindsey Sikora; Rita Katznelson
Journal:  Diving Hyperb Med       Date:  2021-09-30       Impact factor: 1.228

Review 3.  Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19.

Authors:  H-F Wei; S Anchipolovsky; R Vera; G Liang; D-M Chuang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2022-03       Impact factor: 3.784

Review 4.  Colchicine as a Potential Therapeutic Agent Against Cardiovascular Complications of COVID-19: an Exploratory Review.

Authors:  Christodoulos Papadopoulos; Dimitrios Patoulias; Eleftherios Teperikidis; Dimitrios Mouselimis; Anastasios Tsarouchas; Maria Toumpourleka; Aristi Boulmpou; Constantinos Bakogiannis; Michael Doumas; Vassilios P Vassilikos
Journal:  SN Compr Clin Med       Date:  2020-08-04

Review 5.  SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities.

Authors:  Marcin F Osuchowski; Federico Aletti; Jean-Marc Cavaillon; Stefanie B Flohé; Evangelos J Giamarellos-Bourboulis; Markus Huber-Lang; Borna Relja; Tomasz Skirecki; Andrea Szabó; Marc Maegele
Journal:  Shock       Date:  2020-10       Impact factor: 3.454

6.  Rate of Intensive Care Unit admission and outcomes among patients with coronavirus: A systematic review and Meta-analysis.

Authors:  Semagn Mekonnen Abate; Siraj Ahmed Ali; Bahiru Mantfardo; Bivash Basu
Journal:  PLoS One       Date:  2020-07-10       Impact factor: 3.240

Review 7.  No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science.

Authors:  Monica Salerno; Francesco Sessa; Amalia Piscopo; Angelo Montana; Marco Torrisi; Federico Patanè; Paolo Murabito; Giovanni Li Volti; Cristoforo Pomara
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

8.  Redundancy and methodological issues in articles on COVID-19.

Authors:  Dino Papes; Ana Jeroncic; Elizabeta Ozimec
Journal:  Eur J Clin Invest       Date:  2020-06-07       Impact factor: 5.722

9.  Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study.

Authors:  Vincenzo De Santis; Alberto Corona; Domenico Vitale; Cecilia Nencini; Antonella Potalivo; Anna Prete; Gianluca Zani; Anna Malfatto; Luigi Tritapepe; Stefania Taddei; Alessandro Locatelli; Vittorio Sambri; Maurizio Fusari; Mervyn Singer
Journal:  Infection       Date:  2021-07-14       Impact factor: 3.553

10.  Additive treatment considerations in COVID-19-The clinician's perspective on extracorporeal adjunctive purification techniques.

Authors:  Justyna Swol; Roberto Lorusso
Journal:  Artif Organs       Date:  2020-07-07       Impact factor: 2.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.